Cargando…

Impact of intracellular glyceraldehyde-derived advanced glycation end-products on human hepatocyte cell death

Hepatocyte cell death is a key feature of nonalcoholic steatohepatitis (NASH); however, the pathogenesis of NASH currently remains unclear. We aimed to investigate the effects of intracellular glyceraldehyde (GA)-derived advanced glycation end-products (GA-AGEs) on human hepatocyte cell death. The a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sakasai-Sakai, Akiko, Takata, Takanobu, Takino, Jun-ichi, Takeuchi, Masayoshi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5660208/ https://www.ncbi.nlm.nih.gov/pubmed/29079763 http://dx.doi.org/10.1038/s41598-017-14711-3

Ejemplares similares

Generation of glyceraldehyde-derived advanced glycation end-products in pancreatic cancer cells and the potential of tumor promotion
por: Takata, Takanobu, et al.
Publicado: (2017)

Impact of intracellular toxic advanced glycation end-products (TAGE) on murine myoblast cell death
por: Takata, Takanobu, et al.
Publicado: (2020)

Evidence for Toxic Advanced Glycation End-Products Generated in the Normal Rat Liver
por: Takata, Takanobu, et al.
Publicado: (2019)

Intracellular Toxic Advanced Glycation End-Products May Induce Cell Death and Suppress Cardiac Fibroblasts
por: Takata, Takanobu, et al.
Publicado: (2022)

Cancer Malignancy Is Enhanced by Glyceraldehyde-Derived Advanced Glycation End-Products
por: Takino, Jun-Ichi, et al.
Publicado: (2010)

Intracellular toxic advanced glycation end-products in cardiomyocytes may cause cardiovascular disease
por: Takata, Takanobu, et al.
Publicado: (2019)

Intracellular Toxic Advanced Glycation End-Products Promote the Production of Reactive Oxygen Species in HepG2 Cells
por: Sakasai-Sakai, Akiko, et al.
Publicado: (2020)

Intracellular Toxic Advanced Glycation End-Products in 1.4E7 Cell Line Induce Death with Reduction of Microtubule-Associated Protein 1 Light Chain 3 and p62
por: Takata, Takanobu, et al.
Publicado: (2022)

The Association between Accumulation of Toxic Advanced Glycation End-Products and Cytotoxic Effect in MC3T3-E1 Cells
por: Sakasai-Sakai, Akiko, et al.
Publicado: (2022)

The Relevance of Toxic AGEs (TAGE) Cytotoxicity to NASH Pathogenesis: A Mini-Review
por: Sakasai-Sakai, Akiko, et al.
Publicado: (2019)

Immunological evidence for in vivo production of novel advanced glycation end-products from 1,5-anhydro-D-fructose, a glycogen metabolite
por: Sakasai-Sakai, Akiko, et al.
Publicado: (2019)

RasGRP2 inhibits glyceraldehyde-derived toxic advanced glycation end-products from inducing permeability in vascular endothelial cells
por: Takino, Jun-ichi, et al.
Publicado: (2021)

Toxic AGE (TAGE) Theory for the Pathophysiology of the Onset/Progression of NAFLD and ALD
por: Takeuchi, Masayoshi, et al.
Publicado: (2017)

Effects of Toxic AGEs (TAGE) on Human Health
por: Takeuchi, Masayoshi, et al.
Publicado: (2022)

Intracellular Toxic AGEs (TAGE) Triggers Numerous Types of Cell Damage
por: Takeuchi, Masayoshi, et al.
Publicado: (2021)

Serum levels of 1,5-anhydroglucitol and 1,5-anhydrofructose-derived advanced glycation end products in patients undergoing hemodialysis
por: Tanaka, Kenji, et al.
Publicado: (2021)

Glyceraldehyde-Derived Advanced Glycation End Products Accumulate Faster Than N(ε)-(Carboxymethyl) Lysine
por: Yokota, Mami, et al.
Publicado: (2017)

Pyridoxamine and Aminoguanidine Attenuate the Abnormal Aggregation of β-Tubulin and Suppression of Neurite Outgrowth by Glyceraldehyde-Derived Toxic Advanced Glycation End-Products
por: Ooi, Hayahide, et al.
Publicado: (2022)

Is the Novel Slot Blot a Useful Method for Quantification of Intracellular Advanced Glycation End-Products?
por: Takata, Takanobu
Publicado: (2023)

Glyceraldehyde-derived advanced glycation end-products having pyrrolopyridinium-based crosslinks
por: Shigeta, Tomoaki, et al.
Publicado: (2021)

The Effect of Glyceraldehyde-Derived Advanced Glycation End Products on β-Tubulin-Inhibited Neurite Outgrowth in SH-SY5Y Human Neuroblastoma Cells
por: Nasu, Ryuto, et al.
Publicado: (2020)

Positive Association Between Serum Level of Glyceraldehyde-Derived Advanced Glycation End Products and Vascular Inflammation Evaluated by [(18)F]Fluorodeoxyglucose Positron Emission Tomography
por: Tahara, Nobuhiro, et al.
Publicado: (2012)

Assessment of the Concentrations of Various Advanced Glycation End-Products in Beverages and Foods That Are Commonly Consumed in Japan
por: Takeuchi, Masayoshi, et al.
Publicado: (2015)

Involvement of Intracellular TAGE and the TAGE–RAGE–ROS Axis in the Onset and Progression of NAFLD/NASH
por: Sakasai-Sakai, Akiko, et al.
Publicado: (2023)

Glyceraldehyde caused Alzheimer’s disease-like alterations in diagnostic marker levels in SH-SY5Y human neuroblastoma cells
por: Koriyama, Yoshiki, et al.
Publicado: (2015)

Potential of an Interorgan Network Mediated by Toxic Advanced Glycation End-Products in a Rat Model
por: Inoue, Shinya, et al.
Publicado: (2020)

Neuropathy induced by exogenously administered advanced glycation end‐products in rats
por: Nishizawa, Yusuke, et al.
Publicado: (2010)

Acetaldehyde-Derived Advanced Glycation End-Products Promote Alcoholic Liver Disease
por: Hayashi, Nobuhiko, et al.
Publicado: (2013)

Novel In Vitro Assay of the Effects of Kampo Medicines against Intra/Extracellular Advanced Glycation End-Products in Oral, Esophageal, and Gastric Epithelial Cells
por: Takata, Takanobu, et al.
Publicado: (2023)

Insulin resistance is an independent correlate of high serum levels of advanced glycation end products (AGEs) and low testosterone in non-diabetic men
por: Tahara, Nobuhiro, et al.
Publicado: (2010)

Proteomic Investigation of Glyceraldehyde-Derived Intracellular AGEs and Their Potential Influence on Pancreatic Ductal Cells
por: Senavirathna, Lakmini, et al.
Publicado: (2021)

Atorvastatin Reduces Proteinuria in Non-Diabetic Chronic Kidney Disease Patients Partly via Lowering Serum Levels of Advanced Glycation End Products (AGEs)
por: Nakamura, Tsukasa, et al.
Publicado: (2010)

Advanced glycation end products, oxidative stress and diabetic nephropathy
por: Yamagishi, Sho-ichi, et al.
Publicado: (2010)

Involvement of TAGE-RAGE System in the Pathogenesis of Diabetic Retinopathy
por: Takeuchi, Masayoshi, et al.
Publicado: (2010)

Role of receptor for advanced glycation end products (RAGE) in liver disease
por: Yamagishi, Sho-ichi, et al.
Publicado: (2015)

Relationship between Advanced Glycation End Products and Plaque Progression in Patients with Acute Coronary Syndrome: The JAPAN-ACS Sub-study
por: Fukushima, Yoshifumi, et al.
Publicado: (2013)

Advanced glycation end products and cognitive impairment in schizophrenia
por: Kobori, Akiko, et al.
Publicado: (2021)

Advanced Glycation End Products and Psoriasis
por: Maurelli, Martina, et al.
Publicado: (2023)

Inhibition of Advanced Glycation End-Products by Tamarindus indica and Mitragyna inermis Extracts and Effects on Human Hepatocyte and Fibroblast Viability
por: Ouédraogo, Relwendé Justin, et al.
Publicado: (2023)

Role of Hyperglycemia-Induced Advanced Glycation End Product (AGE) Accumulation in Atherosclerosis
por: Yamagishi, Sho-ichi, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_6qij81bqu73dgmt80vfp5cpdak